264 related articles for article (PubMed ID: 10904019)
1. Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase.
Yamashita T; Kawashima S; Ohashi Y; Ozaki M; Rikitake Y; Inoue N; Hirata K; Akita H; Yokoyama M
Hypertension; 2000 Jul; 36(1):97-102. PubMed ID: 10904019
[TBL] [Abstract][Full Text] [Related]
2. Vasomotor control in mice overexpressing human endothelial nitric oxide synthase.
van Deel ED; Merkus D; van Haperen R; de Waard MC; de Crom R; Duncker DJ
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1144-53. PubMed ID: 17496213
[TBL] [Abstract][Full Text] [Related]
3. Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase.
Ohashi Y; Kawashima S; Hirata Ki; Yamashita T; Ishida T; Inoue N; Sakoda T; Kurihara H; Yazaki Y; Yokoyama M
J Clin Invest; 1998 Dec; 102(12):2061-71. PubMed ID: 9854041
[TBL] [Abstract][Full Text] [Related]
4. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.
Hussain MB; Hobbs AJ; MacAllister RJ
Br J Pharmacol; 1999 Nov; 128(5):1082-8. PubMed ID: 10556946
[TBL] [Abstract][Full Text] [Related]
5. Role of endogenous nitric oxide generation in the regulation of vascular tone and reactivity in small vessels as investigated in transgenic mice using synchrotron radiation microangiography.
Yamashita T; Kawashima S; Ozaki M; Namiki M; Satomi-Kobayashi S; Seno T; Matsuda Y; Inoue N; Hirata K; Akita H; Umetani K; Tanaka E; Mori H; Yokoyama M
Nitric Oxide; 2001; 5(5):494-503. PubMed ID: 11587564
[TBL] [Abstract][Full Text] [Related]
6. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase.
Brandes RP; Kim D; Schmitz-Winnenthal FH; Amidi M; Gödecke A; Mülsch A; Busse R
Hypertension; 2000 Jan; 35(1 Pt 2):231-6. PubMed ID: 10642303
[TBL] [Abstract][Full Text] [Related]
7. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide inhibits alpha2-adrenoceptor-mediated endothelium-dependent vasodilation.
Thorin E; Huang PL; Fishman MC; Bevan JA
Circ Res; 1998 Jun; 82(12):1323-9. PubMed ID: 9648729
[TBL] [Abstract][Full Text] [Related]
9. Impaired effect of salt loading on nitric oxide-mediated relaxation in aortas from stroke-prone spontaneously hypertensive rats.
Kagota S; Kubota Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
Clin Exp Pharmacol Physiol; 2007; 34(1-2):48-54. PubMed ID: 17201735
[TBL] [Abstract][Full Text] [Related]
10. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases.
Hussain MB; MacAllister RJ; Hobbs AJ
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1151-9. PubMed ID: 11179059
[TBL] [Abstract][Full Text] [Related]
12. Relationships between nitric oxide-mediated endothelial function, eNOS coupling and blood pressure revealed by eNOS-GTP cyclohydrolase 1 double transgenic mice.
Adlam D; Bendall JK; De Bono JP; Alp NJ; Khoo J; Nicoli T; Yokoyama M; Kawashima S; Channon KM
Exp Physiol; 2007 Jan; 92(1):119-26. PubMed ID: 17012144
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase.
Jadeski LC; Chakraborty C; Lala PK
Int J Cancer; 2003 Sep; 106(4):496-504. PubMed ID: 12845643
[TBL] [Abstract][Full Text] [Related]
14. High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation.
Jebelovszki E; Kiraly C; Erdei N; Feher A; Pasztor ET; Rutkai I; Forster T; Edes I; Koller A; Bagi Z
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2558-64. PubMed ID: 18408126
[TBL] [Abstract][Full Text] [Related]
15. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
Takimoto E; Champion HC; Belardi D; Moslehi J; Mongillo M; Mergia E; Montrose DC; Isoda T; Aufiero K; Zaccolo M; Dostmann WR; Smith CJ; Kass DA
Circ Res; 2005 Jan; 96(1):100-9. PubMed ID: 15576651
[TBL] [Abstract][Full Text] [Related]
16. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.
Díaz-Troya S; Najib S; Sánchez-Margalet V
Regul Pept; 2005 Feb; 125(1-3):41-6. PubMed ID: 15582712
[TBL] [Abstract][Full Text] [Related]
17. Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity?
Neves KB; Lobato NS; Lopes RA; Filgueira FP; Zanotto CZ; Oliveira AM; Tostes RC
Clin Sci (Lond); 2014 Jul; 127(2):111-22. PubMed ID: 24498891
[TBL] [Abstract][Full Text] [Related]
18. Vascular smooth muscle cell-directed overexpression of heme oxygenase-1 elevates blood pressure through attenuation of nitric oxide-induced vasodilation in mice.
Imai T; Morita T; Shindo T; Nagai R; Yazaki Y; Kurihara H; Suematsu M; Katayama S
Circ Res; 2001 Jul; 89(1):55-62. PubMed ID: 11440978
[TBL] [Abstract][Full Text] [Related]
19. Increased sensitivity to endothelial nitric oxide (NO) contributes to arterial normotension in mice with vascular smooth muscle-selective deletion of the atrial natriuretic peptide (ANP) receptor.
Sabrane K; Gambaryan S; Brandes RP; Holtwick R; Voss M; Kuhn M
J Biol Chem; 2003 May; 278(20):17963-8. PubMed ID: 12637561
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cAMP-mediated vasorelaxation by endothelial nitric oxide and basal cGMP in vascular smooth muscle.
Toyoshima H; Nasa Y; Hashizume Y; Koseki Y; Isayama Y; Kohsaka Y; Yamada T; Takeo S
J Cardiovasc Pharmacol; 1998 Oct; 32(4):543-51. PubMed ID: 9781922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
